Clinical Trials Browser

Phase 2 × OTHER × Thyrotropin-Releasing Hormone × Clear all

NCT00790296 2017-12-28

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Phase 2 Terminated

11 enrolled 5 charts

Cancer-related Fatigue